ARTICLE | Emerging Company Profile
BioMetrx: RASS restoration
BioMetrx developing plant-derived Rasstore to reduce prostate cancer growth
March 26, 2012 7:00 AM UTC
BioMetrx LLC has early data for its Rasstore suggesting that restoring levels of the tumor suppressor gene RASSF1A may lead to superior safety and efficacy compared to current prostate cancer therapies.
Rasstore selectively inhibits an isoform of DNA methyltransferase, which in turn leads to up-regulation of Ras association domain family 1A (RASSF1A). BioMetrx believes up-regulation of RASSF1A prevents tumor growth...